VIROBAY is a clinical-stage pharmaceutical company focused on novel treatments for hepatitis C, pain, and auto-immune diseases. The company was originally a spin-out of Celera.
Location: United States, California, Menlo Park
Employees: 1-10
Total raised: $8M
Founded date: 2006
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.07.2014 | Series B | $8M | - |
Mentions in press and media 2
| Date | Title | Description |
| 16.07.2014 | Virobay Completes $8M Series B Round | MENLO PARK, CA, Clinical stage pharmaceutical company announced the closing of an expanded Series B second tranche financing of $8.0 million. >> Click here for more funding data on Virobay >> To export Virobay funding data t... |
| 07.09.2006 | Virobay raises $5.47 for virtual biopharma | Virobay Inc., a San Francisco-based virtual biopharma company, has secured $5.47 million of a $31.5 million Series A round, according to a regulatory filing cited by PE Week Wire. Backers include TPG Biotechnology Partners, Sutter Hill Vent... |